005690.KS
005690.KS
KR7005690003
Pharmicell
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 114.061.538.470 64.851.303.830
75.9%
Cost of Revenue 63.384.963.030 43.521.158.230
45.6%
Gross Profit 50.676.575.440 21.330.145.600
137.6%
16.372.541.000 16.674.509.000
1.8%
Operating Income 34.304.034.440 4.655.636.600
636.8%
Pretax Income 34.767.366.550 6.263.974.720
455.0%
Net Income Common Stockholders 40.288.986.390 6.331.277.000
536.3%
-- --
--
-- --
--
ende